{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:43:49Z","timestamp":1792784629149,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ygyno.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T01:18:53Z","timestamp":1550539133000},"page":"368-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.02.002_bb0005","series-title":"Morrow's Gynecologic Cancer Surgery","first-page":"513","article-title":"Surgery for cervical neoplasia","author":"Sideri","year":"2013"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ajog.2016.06.031","article-title":"National trends in total pelvic exenteration for gynecologic malignancies","volume":"215","author":"Chatterjee","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.06.034","article-title":"Overall survival after pelvic exenteration for gynecologic malignancy","volume":"134","author":"Westin","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2005.10.011","article-title":"Total pelvic exenteration: the Albert Einstein College of Medicine\/Montefiore Medical Center Experience (1987 to 2003)","volume":"101","author":"Goldberg","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","article-title":"Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan","volume":"114","author":"Maggioni","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","article-title":"Pelvic exenteration in gynecologic oncology: a single institution study over 20 years","volume":"122","author":"Benn","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0040","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/ijgc-00009577-200505000-00010","article-title":"Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute","volume":"15","author":"Sharma","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2010.11.044","article-title":"Pelvic exenteration in the age of modern chemoradiation","volume":"121","author":"McLean","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2013.11.014","article-title":"Pelvic exenteration: impact of age on surgical and oncologic outcomes","volume":"132","author":"Huang","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0055","series-title":"International Population Reports","author":"An Aging World","year":"2015"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0060","author":"Health, United States"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0065","author":"National Comprehensive Cancer Network Clinical Practice Guideline in Oncology"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0070","author":"National Comprehensive Cancer Network Clinical Practice Guideline in Oncology"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0075","series-title":"Healthcare Cost and Utilization Project (HCUP)","author":"HCUP National Inpatient Sample (NIS)","year":"2001"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0100","article-title":"Trends of uterine carcinosarcoma in the United States","volume":"29","author":"Matsuo","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2019.02.002_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2012.01.010","article-title":"The effect of body mass index on surgical outcomes and survival following pelvic exenteration","volume":"125","author":"Iglesias","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2018.10.036","article-title":"Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies","volume":"152","author":"Tortorella","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0125","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e68","article-title":"The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer","volume":"29","author":"Jalloul","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ygyno.2015.02.001","article-title":"Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?","volume":"137","author":"Aviki","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2005.05.034","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA","volume":"99","author":"Berek","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0140","first-page":"1027","article-title":"Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix","volume":"73","author":"Shingleton","year":"1989","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0090-8258(89)90020-6","article-title":"Pelvic exenteration: factors associated with major surgical morbidity","volume":"35","author":"Soper","year":"1989","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/gyno.2002.6780","article-title":"Vaginal reconstruction at the time of pelvic exenteration: a surgical and psychosexual analysis of techniques","volume":"87","author":"Mirhashemi","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2019.02.002_bb0155","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/SAP.0000000000001578","article-title":"Rectus abdominis myofascial flap for vaginal reconstruction after pelvic exenteration","volume":"81","author":"Cortinovis","year":"2018","journal-title":"Ann. Plast. Surg."}],"updated-by":[{"DOI":"10.1016\/j.ygyno.2020.01.025","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819301052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819301052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T03:55:03Z","timestamp":1579060503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819301052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0090825819301052"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.02.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}